Dr. Gustafson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9 Rio Ct
San Francisco, CA 94127
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 2008 - 2011
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2005 - 2008
- University of Texas Medical Branch School of MedicineClass of 2005
- University of Texas Medical BranchPhD, Biological Chemistry and Genetics, 1998 - 2003
- Rice UniversityB.A., Biochemistry/English Literature, 1991 - 1996
Certifications & Licensure
- CA State Medical License 2008 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Best Basic Science Talk in a Parallel Session Advances in Neuroblastoma Research, Toronto, Canada, 2012
- Alex's Lemonade Stand "A" Award 2011
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsThe synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53.Joanna S. Yi, Oscar Sias-Garcia, Nicole Nasholm, Xiaoyu Hu, Amanda Balboni Iniguez
Neoplasia. 2021-06-06 - 27 citationsDrugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood CancersAdam J. Wolpaw, Richard Bayliss, Gabriele Büchel, Chi V. Dang, Martin Eilers
Cancer Research. 2021-01-28 - 19 citations124I-MIBG PET/CT to Monitor Metastatic Disease in Children with Relapsed NeuroblastomaMariam Aboian, Shih-ying Huang, Miguel Hernandez-Pampaloni, Randall A. Hawkins, Henry F. VanBrocklin
Journal of Nuclear Medicine. 2021-01-01
Journal Articles
- Dual blockade of lipid and cyclin-dependent kinases induces synthetic lethality in malignant gliomaCheng CK, Gustafson WC, Charron E, Houseman BT, Zunder E, Goga A, Gray NS, Pollok B, Oakes SA, James CD, Shokat KM, Weiss WA, Fan QW, Proc Natl Acad Sci USA, 7/16/2012
- Tumor Dosimetry Using ((124)I)m-iodobenzylguanidine MicroPET/CT for ((131)I)m-iodobenzylguanidine Treatment of Neuroblastoma in a Murine Xenograft ModelSeo Y, Gustafson WC, Dannoon SF, Nekritz EA, Lee CL, Murphy ST, Vanbrocklin HF, Hernandez-Pampaloni M, Haas-Kogan DA, Weiss WA, Matthay KK, Mol Imaging Biol, 3/2/2012
- Comparison of GLUT1, GLUT3, and GLUT4 mRNA and the subcellular distribution of their proteins in normal human muscleStuart CA, Wen G, Gustafson WC, Thompson EA, Metabolism, 12/1/2000
- Join now to see all
Books/Book Chapters
Lectures
- "Drugging MYCN protein stability though an allosteric transition in Aurora Kinase A" Invited TalkSan Diego, CA - 11/1/2013
- "Drugging MYCN through an allosteric transition in Aurora Kinas A" Invited TalkHong Kong, China - 9/1/2013
- "Drugging MYCN through Aurora Kinase A in Medulloblastoma." Invited TalkFt. Lauderdale, FL - 1/1/2013
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: